EpicSage
1週前
$VSEE News: VSee Health Realizes 20X Expansion of its Hospital Network to 58 Locations
Key Driver for its Enterprise Telehealth Revenue Acceleration
HOUSTON, June 25, 2026 (Newswire.com) - VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solutions, is pleased to announce that its hospital footprint has grown to 58 locations, up from just 3 in approximately two tears. This dramatic ramp of 20-fold over the past two years, has led to a significant +80% growth in revenue in 2025 to $11.4 million.
This growth in the VSee hospital network has been driven by expanding Integrated Delivery Network relationships and multi-year deployments.
VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented, "We have become a pure-play enterprise telehealth provider and are at a major inflection point having reached 58 hospitals. We expect to continue to expand our reach to hundreds of hospitals over the next two years. We are perfectly positioned to achieve a $20 million annual revenue run-rate, sustained gross margins of at least 50% and progress toward profitability."
About VSee Health, Inc.
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.
For more information, please visit our website: https://www.idocvms.com
Forward-Looking Statements
This press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at www.sec.gov.
All forward-looking statements speak only as of the date on which they are made. VSee Health undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement was made, except to the extent required by applicable securities laws.
Investors Contact:
Justin Smith
jsmith@idocvms.com
SOURCE: VSee Health
https://www.stockonhighalert.com/post/vsee-vsee-health-realizes-20x-expansion-of-its-hospital-network-to-58-locations
ProfitScout
1週前
$VSEE News: VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025
HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026.
Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:
+60% revenue growth to $8 million in 2025
+70% revenue growth to $2.5 million in Q1 2026
Approximate reduction of $6.0 million in annual operating expenses
Several large IDN (Integrated Health Network) multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services.
VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented, "Nearly one month since our decision to separate out VSee Lab and we are already seeing improved operational and financial efficiencies. Our team is super driven to ramp and grow existing contracts and identify, prospect and close new contracts from our ever-expanding business pipeline. With our hospital network continuing to grow, margins continuing to improve and operating expenses continuing to be reduced, we believe can achieve $20 million revenue and profitability over the next 12 months is a realistic target."
About VSee Health, Inc.
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.
Source: For more information, please visit our website: https://www.idocvms.com
Forward-Looking Statements
This press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at www.sec.gov.
All forward-looking statements speak only as of the date on which they are made. VSee Health undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement was made, except to the extent required by applicable securities laws.
Investors Contact:
Justin Smith
jsmith@idocvms.com
SOURCE: VSee Health
EpicSage
1週前
$VSEE VSee Health Highlights Business Operations and Financial Success After Recent Strategic Sale
Refocus on Telehealth and Digital Health Solutions That Provided 80% Revenue Growth in 2025
HOUSTON, TX / ACCESS Newswire / June 22, 2026 / VSee Health, Inc. (NASDAQ:VSEE) ("VSee" or the "Company"), a leading provider of telehealth and digital health solution, is pleased to provide an update on its business operations and financial success following its strategic sale of VSee Lab on May 31, 2026.
Pro-forma financials from enhanced focus on iDoc telehealth platform and enterprise healthcare solutions:
+60% revenue growth to $8 million in 2025
+70% revenue growth to $2.5 million in Q1 2026
Approximate reduction of $6.0 million in annual operating expenses
Several large IDN (Integrated Health Network) multi-year contracts that were signed throughout 2025 are continuing to roll out, build revenue and add more telehealth services.
VSee Health Chairman and Chief Executive Officer Dr. Imoigele Aisiku commented, "Nearly one month since our decision to separate out VSee Lab and we are already seeing improved operational and financial efficiencies. Our team is super driven to ramp and grow existing contracts and identify, prospect and close new contracts from our ever-expanding business pipeline. With our hospital network continuing to grow, margins continuing to improve and operating expenses continuing to be reduced, we believe can achieve $20 million revenue and profitability over the next 12 months is a realistic target."
About VSee Health, Inc.
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.
Source: For more information, please visit our website: https://www.idocvms.com
Forward-Looking Statements
This press release contains certain statements that may be deemed to be forward-looking statements within the meaning of the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Such statements may be preceded by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential," or similar words or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are not guarantees of future performance, are based on certain assumptions and are subject to various known and unknown risks and uncertainties, many of which are beyond the control of VSee Health, and cannot be predicted or quantified and consequently, actual results may differ materially from those expressed or implied by such forward-looking statements. More detailed information about VSee Health and the risk factors that may affect the realization of forward-looking statements is set forth in the filings with the Securities and Exchange Commission ("SEC"), including the most recent Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Investors and security holders are urged to read these documents free of charge on the SEC's website at www.sec.gov.
All forward-looking statements speak only as of the date on which they are made. VSee Health undertakes no obligation to update any forward-looking statement or statements to reflect events or circumstances after the date on which such statement was made, except to the extent required by applicable securities laws.
Investors Contact:
Justin Smith
jsmith@idocvms.com
SOURCE: VSee Health
US Market News
3週前
VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO LeadershipJune 11, 2026 8:30 AM
ACCESS NewswireHOUSTON, TX / ACCESS Newswire / June 11, 2026 / VSee Health, Inc. (NASDAQ:VSEE) today announced the completion of a transformative strategic transaction that separates the Company from its former laboratory subsidiary, VSee Lab, eliminates a significant block of outstanding shares, and positions VSee Health to focus exclusively on its core telehealth and digital health platform businesses.Under a Stock Purchase Agreement dated May 31, 2026, VSee Health sold 100% of VSee Lab, Inc. to former Co-Chief Executive Officer and Chairman Milton Chen. In connection with the transaction, Mr. Chen transferred all 2,870,069 shares of VSee Health common stock owned by him back to the Company and assumed responsibility for the remaining liabilities of VSee Lab following closing. The returned shares represent approximately 7% of the Company's outstanding common stock and are expected to significantly improve shareholder alignment while simplifying the Company's capital structure.The transaction marks a significant milestone in VSee Health's ongoing effort to streamline operations, sharpen strategic focus, improve financial performance, and position the Company for long-term growth.Key Benefits of the TransactionComplete separation of the VSee Lab business from VSee Health.Elimination of a non-core and operationally distracting division.Retirement of approximately 7% of outstanding common shares.Streamlined leadership under a single Chief Executive Officer.Enhanced focus on the Company's iDoc telehealth platform and enterprise healthcare solutions.Improved alignment between management, operations, and shareholders.Clearer path toward growth, profitability, and shareholder value creation.Concurrent with the closing, Milton Chen resigned as Co-Chief Executive Officer and Chairman of the Board. Dr. Imoigele Aisiku has assumed the roles of sole Chief Executive Officer and Chairman of the Board and will lead the next phase of the Company's growth strategy. "This transaction represents a decisive turning point for VSee Health," said Dr. Aisiku. "We now have a simpler corporate structure, a stronger alignment with shareholders, and a singular focus on scaling iDoc and our enterprise telehealth platform. Every dollar, every resource, and every member of our team is focused on growth, execution, and building long-term shareholder value."Positioned for the Next Chapter With this transaction completed, VSee Health has eliminated a significant source of operational complexity and can now devote its full attention to expanding its telehealth platform, healthcare enterprise relationships, AI-enabled care solutions, and recurring revenue opportunities. Management believes the Company is emerging from this transaction with a clearer strategic direction, a stronger balance sheet, improved governance, and a more focused operating model. The Company expects the benefits of the divestiture to be reflected in future operating performance and believes it is now better positioned to pursue growth initiatives, strategic partnerships, acquisitions, and shareholder value creation. This transaction is not simply a divestiture. It is a strategic reset that allows VSee Health to focus on what it does best: delivering scalable telehealth solutions to healthcare enterprises while building a stronger and more valuable public company.Contact: VSee Health Justin Smith
VSee Investor Contact:
Imo Aisiku investor@idocvms.comSOURCE: VSee Health Inc.View the original press release on ACCESS NewswireOriginal: VSee Health Completes Strategic Separation of VSee Lab, Retires Approximately 7% of Outstanding Shares, and Transitions to Single CEO Leadership
ProfitScout
1月前
VSEE results so far in 2026 are quite positive. This is a company that should still be on our watch lists.
------------------------------------------------------------------------------------------------------
Key Financial Highlights (Year-over-Year Comparisons)
Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024
Gross margin rose 2% to $7,355,965 from $7,177,580
Operating expenses declined sharply by 76%
The Company strengthened its balance sheet through multiple debt to equity conversions
Cash and liquidity: Cash and cash equivalents increased to $5,266,286 at December 31, 2025, from $326,115 at December 31, 2024
US Market News
3月前
VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance SheetApril 1, 2026 4:00 PM
ACCESS NewswireSAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.Key Financial Highlights (Year-over-Year Comparisons)Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024Gross margin rose 2% to $7,355,965 from $7,177,580Operating expenses declined sharply by 76%The Company strengthened its balance sheet through multiple debt to equity conversionsCash and liquidity: Cash and cash equivalents increased to $5,266,286 at December 31, 2025, from $326,115 at December 31, 2024Key Business HighlightsDuring 2025 VSee Health focused on reducing public expenses associated with the IPO, and growth in its telehealth clinical services group.The company derived its 40% revenue growth by targeting large IDN's (Integrated Health Networks) in the USA. The team signed several large scale multi-year contracts (one for $10 million per year previously announced) in early and mid 2025. The telehealth revenue for new large healthcare institutional accounts takes several months to begin, as the operations are complex and must be integrated into VSee heath's technology before rolling out services. This is particularly important for our investors to understand that a majority of 2025 growth was in the second half of the year, and subsequently provides solid future growth in those accounts during 2026 as services continue to roll out to as many as 20 states this fiscal year. Management is bullish for 2026 growth as these contracts are continuing to build revenue and adding additional telehealth services.VSee Health continues to service government accounts such as NASA. In 2025 VSee Labs Inc was nominated and approved for Fedramp High status with the Federal Government as a technology partner. This was achieved through its HHS (Health and Human Services) contract awarded during 2024 and into 2025. VSee continues to pursue several government healthcare related projects in 2026.VSee Health experienced extremely high legal, accounting, and integration expenses associated with the IPO process in 2024 and 2025. The executive team worked diligently with the Board of Directors to streamline all operations during 2025. VSee believes it can continue to lower its operating costs while growing revenue during 2026.Outlook and Strategic PositionVSee Health enters 2026 with a fully integrated digital-to-physical care platform, scalable AI telehealth infrastructure, and proven high-acuity clinical delivery. The Company continues to target the rapidly growing hybrid care market while focusing on operational efficiencies, contract renewals, and new enterprise wins. Management remains committed to achieving sustainable profitability and delivering long-term shareholder value.Investors and interested parties are encouraged to review the complete 10-K filing, which includes detailed financial statements, Management's Discussion and Analysis, risk factors, and business overview, at www.sec.gov or VSeeHealth.com/investors.About VSee Health, Inc. (Nasdaq: VSEE)VSee Health is a leader in AI-powered telehealth technology, providing configurable virtual care solutions-including secure video, remote monitoring, AI-enhanced workflows, and seamless EHR integrations-for health systems, government agencies, and large enterprises. Through its iDoc subsidiary, the Company also delivers high-acuity specialty physician services in neurology, tele-radiology, cardiac, and critical care via telehealth.Forward-Looking StatementsMatters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.Contact:VSee Health
Anne Chang
media@vsee.comVSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.comSOURCE: VSee Health, Inc.View the original press release on ACCESS NewswireOriginal: VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
ProfitScout
3月前
$VSEE News: VSee Health Reports 2025 Financial Results: Revenue Grows 40% Year-over-Year with a Strong Year End Balance Sheet
SAN JOSE, CA / ACCESS Newswire / April 1, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in AI-powered telehealth technology and high-acuity virtual care solutions, today reported its financial and operational results for the full year ended December 31, 2025. The Company delivered strong top-line growth and meaningful margin improvement while significantly narrowing its net loss.
Key Financial Highlights (Year-over-Year Comparisons)
Revenue increased 40% to $14,618,184 in 2025 from $10,421,352 in 2024
Gross margin rose 2% to $7,355,965 from $7,177,580
Operating expenses declined sharply by 76%
The Company strengthened its balance sheet through multiple debt to equity conversions
Cash and liquidity: Cash and cash equivalents increased to $5,266,286 at December 31, 2025, from $326,115 at December 31, 2024
Key Business Highlights
During 2025 VSee Health focused on reducing public expenses associated with the IPO, and growth in its telehealth clinical services group.
The company derived its 40% revenue growth by targeting large IDN's (Integrated Health Networks) in the USA. The team signed several large scale multi-year contracts (one for $10 million per year previously announced) in early and mid 2025. The telehealth revenue for new large healthcare institutional accounts takes several months to begin, as the operations are complex and must be integrated into VSee heath's technology before rolling out services. This is particularly important for our investors to understand that a majority of 2025 growth was in the second half of the year, and subsequently provides solid future growth in those accounts during 2026 as services continue to roll out to as many as 20 states this fiscal year. Management is bullish for 2026 growth as these contracts are continuing to build revenue and adding additional telehealth services.
VSee Health continues to service government accounts such as NASA. In 2025 VSee Labs Inc was nominated and approved for Fedramp High status with the Federal Government as a technology partner. This was achieved through its HHS (Health and Human Services) contract awarded during 2024 and into 2025. VSee continues to pursue several government healthcare related projects in 2026.
VSee Health experienced extremely high legal, accounting, and integration expenses associated with the IPO process in 2024 and 2025. The executive team worked diligently with the Board of Directors to streamline all operations during 2025. VSee believes it can continue to lower its operating costs while growing revenue during 2026.
Outlook and Strategic Position
VSee Health enters 2026 with a fully integrated digital-to-physical care platform, scalable AI telehealth infrastructure, and proven high-acuity clinical delivery. The Company continues to target the rapidly growing hybrid care market while focusing on operational efficiencies, contract renewals, and new enterprise wins. Management remains committed to achieving sustainable profitability and delivering long-term shareholder value.
Investors and interested parties are encouraged to review the complete 10-K filing, which includes detailed financial statements, Management's Discussion and Analysis, risk factors, and business overview, at www.sec.gov or VSeeHealth.com/investors.
About VSee Health, Inc. (Nasdaq: VSEE)
VSee Health is a leader in AI-powered telehealth technology, providing configurable virtual care solutions-including secure video, remote monitoring, AI-enhanced workflows, and seamless EHR integrations-for health systems, government agencies, and large enterprises. Through its iDoc subsidiary, the Company also delivers high-acuity specialty physician services in neurology, tele-radiology, cardiac, and critical care via telehealth.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contact:
VSee Health
Anne Chang
media@vsee.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health, Inc.
Trooperstocks
4月前
$VSEE News: VSee Unveils World's First Autonomous Telehealth AI Robot at HIMSS 2026
VSee Health
Tue, March 10, 2026 at 9:56 AM EDT
Autonomous, AI-Powered Robot Navigates Directly to Patients' Bedsides - No Staff Escort Required
LAS VEGAS, NV / ACCESS Newswire / March 10, 2026 / VSee (NASDAQ:VSEE), the leader in telehealth platform innovation, today announced the launch of the VSee AI Robot at HIMSS 2026 - the world's first fully autonomous telehealth AI robot purpose-built for hospital and health system deployment. The VSee AI Robot enables remote clinicians to navigate directly to a patient's bedside without requiring onsite staff assistance, delivering true virtual rounding, rapid telestroke response, and specialist coverage across emergency departments and ICUs at scale.
VSee Health
The launch marks a pivotal inflection point in care delivery: For the first time, a single autonomous robot can replace or augment multiple manual workflows simultaneously - from remote physician rounding to medication and supplies delivery - while integrating seamlessly into existing clinical AI ecosystems through VSee's proprietary AI Workflow Engine.
"We built the VSee AI Robot to solve the hardest problem in healthcare staffing: doing more with less, without sacrificing the human connection at the bedside," said Dr. Milton Chen, CEO of VSee. "This isn't a cart with a screen. This is an autonomous clinical teammate that multiplies what every provider on your team can do."
Autonomous Navigation Meets Clinical-Grade Intelligence
Unlike traditional telepresence carts that require staff to physically escort or reposition them, the VSee AI Robot uses advanced LiDAR navigation to independently travel hospital corridors, enter patient rooms, and position itself at the bedside - day or night, with 30X optical and infrared night vision. Its surgical-grade display delivers high-definition virtual encounters while programmable drawers enable secure medication and supply delivery on the same autonomous pass.
Key clinical capabilities include:
Remote physician rounding & specialist consults - multisite coverage across ED, ICU, and med-surg
Telestroke & rapid response - autonomous dispatch to bedside within minutes
Patient check-in & triage - reducing front-line staff burden at intake
Medication & supply delivery - programmable, secure, auditable
Secure patient identification - HIPAA-compliant, role-based access
Powered by the VSee AI Workflow Engine: Designed for 100+ Clinical AI Capabilities, Zero IT Rebuild
The VSee AI Robot is powered by the VSee AI Workflow Engine, a no-code/low-code AI activation layer that enables hospitals to deploy and govern a library of clinical AI modules - from AI Copilot-assisted scheduling and coding to Early Warning vitals deterioration alerts and Stroke CT Hemorrhage notifications - without rebuilding existing IT infrastructure or enduring 12-month integration cycles.
The platform's modular Building Blocks architecture means health systems can configure and scale in days, not months - with VSee guaranteeing common customizations in as little as 1 day to 1 month.
Proven at scale, VSee's telehealth platform already powers over 1.5 million video encounters per month, and a capacity of 1,800+ appointments per day, and helped clients like LA County Department of Mental Health onboard 800+ providers in under 7 days.
Immediate Financial & Operational ROI
The VSee AI Robot is designed to deliver measurable ROI from day one:
Optimize staff utilization - autonomous navigation eliminates the need for escort staff on virtual rounds
Reduce staffing costs - one robot enables remote specialists to cover multiple facilities simultaneously
Increase revenue - expand specialist service lines (telestroke, tele-ICU) without adding headcount
See It Live at HIMSS 2026
The VSee AI Robot will be on live demonstration at HIMSS 2026 in Las Vegas. Attendees can experience autonomous bedside navigation, live virtual rounding workflows, and the VSee AI Workflow Engine dashboard in person at two locations on the show floor:
Live Robot Demo - VSee Booth #4468 | Watch the VSee AI Robot navigate and conduct a virtual patient encounter in real time
VSee Platform Experience - VSee Booth #4468 | Deep-dive into the AI Workflow Engine, Building Blocks architecture, and integration ecosystem
Schedule a private meeting or demo at HIMSS: sales@vsee.com | vsee.com
About VSee Health
VSee is a leading telehealth platform company trusted by major health systems, federal agencies, and digital health innovators. Built on a no-code/low-code Building Blocks architecture, VSee's unified platform powers virtual care, clinical AI workflows, and now autonomous robotic telehealth delivery. VSee's Integration Ecosystem features rich data connectors and expert in-house integration teams, enabling a superior patient experience and efficient provider workflows - for the lowest lifecycle cost in the industry.
For more information, visit vsee.com or contact sales@vsee.com.
ProfitScout
4月前
VSEE is making key corporate connections to build a powerful global telehealth network that is needed today more than ever.
$VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery
SAN JOSE, CA / ACCESS Newswire / February 5, 2026 / VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth and enterprise virtual care solutions, today announced a strategic managed services partnership with GoMyRx, a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem, designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide.
GoMyRx currently operates a national prescription fulfillment platform supporting annual gross transaction volume exceeding $10 million, providing existing operational scale and infrastructure capacity to support the expanded partnership. Under the managed services agreement, GoMyRx will serve as VSEE Health's primary operational integration partner supporting prescription workflow coordination, medication fulfillment operations, and direct-to-patient delivery services connected to VSEE Health's enterprise telehealth infrastructure.
The integrated platform connects VSEE Health's telehealth infrastructure - including secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations - with GoMyRx's fulfillment operations and GoMyDocs' pharmaceutical compounding and logistics network.
"Partnering with GoMyRx under a managed services model enables VSEE Health to extend our virtual care infrastructure into integrated medication delivery workflows," said Dr. Imo Aisiku, Co-CEO of VSEE Health. "This collaboration strengthens platform interoperability, enhances care delivery efficiency, and supports sustainable value creation across healthcare delivery networks."
"Partnering with VSEE Health and leveraging our affiliate relationship with GoMyDocs enables GoMyRx to deliver a fully integrated healthcare experience," said Garry Westbrook, CEO of GoMyRx. "By connecting VSEE's virtual care infrastructure with GoMyDocs' pharmaceutical compounding capabilities and our direct-to-patient medication fulfillment platform, we are advancing our shared goal of expanding access to personalized healthcare."
"This partnership represents a significant milestone for the GoMyDocs and GoMyRx platform ecosystem," said George Merwin, COO of GoMyDocs. "By aligning GoMyDocs' infrastructure with VSEE's telehealth technology and GoMyRx's delivery platform, we are building a seamless digital-to-physical care delivery model."
About VSee Health
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.
About Go My Docs
Go My Docs is a national platform specializing in 503A/503B compounding, large-scale medical and nutraceutical manufacturing, nationwide fulfillment, and clinical operations support, helping healthcare partners scale with compliance and innovation.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company's anticipated use of proceeds from the offering; and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contact:
VSee Health
Anne Chang
media@vsee.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health, Inc.
Trooperstocks
5月前
$VSEE -GoMyRx currently operates a national prescription fulfillment platform supporting annual gross transaction volume exceeding $10 million, providing existing operational scale and infrastructure capacity to support the expanded partnership. Under the managed services agreement, GoMyRx will serve as VSEE Health's primary operational integration partner supporting prescription workflow coordination, medication fulfillment operations, and direct-to-patient delivery services connected to VSEE Health's enterprise telehealth infrastructure.
The integrated platform connects VSEE Health's telehealth infrastructure - including secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations - with GoMyRx's fulfillment operations and GoMyDocs' pharmaceutical compounding and logistics network.
"Partnering with GoMyRx under a managed services model enables VSEE Health to extend our virtual care infrastructure into integrated medication delivery workflows," said Dr. Imo Aisiku, Co-CEO of VSEE Health. "This collaboration strengthens platform interoperability, enhances care delivery efficiency, and supports sustainable value creation across healthcare delivery networks."
US Market News
5月前
VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare DeliveryFebruary 5, 2026 8:30 AM
ACCESS NewswireSAN JOSE, CA / ACCESS Newswire / February 5, 2026 / VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth and enterprise virtual care solutions, today announced a strategic managed services partnership with GoMyRx, a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem, designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide.GoMyRx currently operates a national prescription fulfillment platform supporting annual gross transaction volume exceeding $10 million, providing existing operational scale and infrastructure capacity to support the expanded partnership. Under the managed services agreement, GoMyRx will serve as VSEE Health's primary operational integration partner supporting prescription workflow coordination, medication fulfillment operations, and direct-to-patient delivery services connected to VSEE Health's enterprise telehealth infrastructure.The integrated platform connects VSEE Health's telehealth infrastructure - including secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations - with GoMyRx's fulfillment operations and GoMyDocs' pharmaceutical compounding and logistics network."Partnering with GoMyRx under a managed services model enables VSEE Health to extend our virtual care infrastructure into integrated medication delivery workflows," said Dr. Imo Aisiku, Co-CEO of VSEE Health. "This collaboration strengthens platform interoperability, enhances care delivery efficiency, and supports sustainable value creation across healthcare delivery networks.""Partnering with VSEE Health and leveraging our affiliate relationship with GoMyDocs enables GoMyRx to deliver a fully integrated healthcare experience," said Garry Westbrook, CEO of GoMyRx. "By connecting VSEE's virtual care infrastructure with GoMyDocs' pharmaceutical compounding capabilities and our direct-to-patient medication fulfillment platform, we are advancing our shared goal of expanding access to personalized healthcare.""This partnership represents a significant milestone for the GoMyDocs and GoMyRx platform ecosystem," said George Merwin, COO of GoMyDocs. "By aligning GoMyDocs' infrastructure with VSEE's telehealth technology and GoMyRx's delivery platform, we are building a seamless digital-to-physical care delivery model."About VSee HealthVSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.About Go My DocsGo My Docs is a national platform specializing in 503A/503B compounding, large-scale medical and nutraceutical manufacturing, nationwide fulfillment, and clinical operations support, helping healthcare partners scale with compliance and innovation.Forward-Looking StatementsMatters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company's anticipated use of proceeds from the offering; and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.Contact:
VSee Health
Anne Chang
media@vsee.comVSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.comSOURCE: VSee Health, Inc.View the original press release on ACCESS NewswireOriginal: VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery
Trooperstocks
5月前
$VSEE MAJOR NEWS OUT!! VSEE Health Announces Strategic Managed Services Partnership With GoMyRx, an Affiliate of GoMyDocs, to Accelerate Integrated Digital Healthcare Delivery
Thursday, 05 February 2026 08:30 AM
Topic:
Partnerships
SAN JOSE, CA / ACCESS Newswire / February 5, 2026 / VSEE Health, Inc. (NASDAQ:VSEE), a provider of AI-enabled telehealth and enterprise virtual care solutions, today announced a strategic managed services partnership with GoMyRx, a digital prescription fulfillment platform and affiliate company of the GoMyDocs healthcare ecosystem, designed to expand integrated digital healthcare delivery capabilities and support telehealth-enabled medication fulfillment nationwide.
GoMyRx currently operates a national prescription fulfillment platform supporting annual gross transaction volume exceeding $10 million, providing existing operational scale and infrastructure capacity to support the expanded partnership. Under the managed services agreement, GoMyRx will serve as VSEE Health's primary operational integration partner supporting prescription workflow coordination, medication fulfillment operations, and direct-to-patient delivery services connected to VSEE Health's enterprise telehealth infrastructure.
The integrated platform connects VSEE Health's telehealth infrastructure - including secure video visits, AI-assisted clinical workflows, remote patient monitoring, and EHR integrations - with GoMyRx's fulfillment operations and GoMyDocs' pharmaceutical compounding and logistics network.
"Partnering with GoMyRx under a managed services model enables VSEE Health to extend our virtual care infrastructure into integrated medication delivery workflows," said Dr. Imo Aisiku, Co-CEO of VSEE Health. "This collaboration strengthens platform interoperability, enhances care delivery efficiency, and supports sustainable value creation across healthcare delivery networks."
"Partnering with VSEE Health and leveraging our affiliate relationship with GoMyDocs enables GoMyRx to deliver a fully integrated healthcare experience," said Garry Westbrook, CEO of GoMyRx. "By connecting VSEE's virtual care infrastructure with GoMyDocs' pharmaceutical compounding capabilities and our direct-to-patient medication fulfillment platform, we are advancing our shared goal of expanding access to personalized healthcare."
"This partnership represents a significant milestone for the GoMyDocs and GoMyRx platform ecosystem," said George Merwin, COO of GoMyDocs. "By aligning GoMyDocs' infrastructure with VSEE's telehealth technology and GoMyRx's delivery platform, we are building a seamless digital-to-physical care delivery model."
About VSee Health
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States.
About Go My Docs
Go My Docs is a national platform specializing in 503A/503B compounding, large-scale medical and nutraceutical manufacturing, nationwide fulfillment, and clinical operations support, helping healthcare partners scale with compliance and innovation.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company's anticipated use of proceeds from the offering; and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contact:
VSee Health
Anne Chang
media@vsee.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health, Inc.
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/vsee-health-announces-strategic-managed-services-partnership-with-gom-1133883
ProfitScout
5月前
$VSEE News: VSee and DocBox Announce Strategic Partnership to Launch the First Augmented Intelligence Platform for Virtual ICU
Creating a scalable, AI-native Virtual ICU platform that drives new recurring revenue and enterprise value
SAN JOSE, CALIFORNIA / ACCESS Newswire / January 29, 2026 / VSee Health, Inc. (Nasdaq:VSEE), a leader in enterprise telehealth and AI-powered virtual care, today announced a strategic partnership with DocBox, the first Augmented Intelligence platform for critical care, to create a next-generation Virtual ICU operating system for hospitals worldwide.
This partnership marks a fundamental shift in how AI is deployed in healthcare.
Unlike traditional AI solutions built on static records and retrospective data, the joint VSee-DocBox solution embeds DocBox Augmented intelligence platform directly into live clinical workflows powered by continuous bedside device data -- transforming real-time bedside data into clinically actionable intelligence for Virtual ICU. Thus it extends VSee's telehealth platform layer from a unified communications layer into a full-stack AI operating system for critical care.
Through this strategic partnership, VSee's telehealth and AI workflows are powered by DocBox's, vendor-agnostic bedside data infrastructure, enabling hospitals to operationalize real-time, structured clinical data across every ICU device, monitor, and system.
The result is a reimbursement-ready, AI-native Virtual ICU platform that allows hospitals to:
Deliver remote critical care at scale
Expand revenue per bed through automated billing capture
Deploy AI copilots on live physiology
Retain ownership of their clinical data
Embed VSee into core clinical operations
How the Platform Creates Enterprise Value
With VSee as the system of engagement and DocBox as the system of intelligence, the joint platform offers:
Remote ICU at Scale: Health systems deploy 24/7 remote intensivist coverage across multiple hospitals and sites.
Automated Revenue Engine: Billable ICU interventions are detected and structured automatically into the EHR.
AI on Real Data: Clinical copilots operate on live physiologic signals, not just text notes.
Operational Leverage: Automating bedside device documentation returns significant nursing time to direct patient care.
"AI in healthcare has been limited by the lack of real-time clinical data infrastructure," said Bobby Shah, CEO of DocBox. "VSee brings global telehealth distribution. DocBox provides the intelligence layer. Together, we've built the missing operating system that makes AI in critical care real, scalable, and economically defensible."
"With DocBox, we now operate on a live clinical intelligence backbone, positioning VSee at the center of the next generation of virtual healthcare," said Milton Chen, Co-CEO of VSee Health. "This partnership deepens VSee's critical care capabilities and strengthens our position as a comprehensive AI healthcare platform."
The companies aim to support hospitals - including rural health hospitals implementing CMS Rural Health Transformation Program initiatives-in expanding access to critical care specialists, improving clinician efficiency, and enhancing patient safety across ICU and step-down environments.
Webinar Event: On-demand ICU - Future of Sustainable Rural Healthcare
To further support rural and community hospitals navigating high-acuity care challenges, VSee will host a live webinar + Q&A on February 4, 2026, from 11:00 AM to 12:00 PM PT, featuring DocBox CEO Bobby Shah and moderated by VSee Health Co-CEO Dr. Milton Chen. The session will explore how hospitals can use on-demand Virtual and mobile ICU infrastructure to stop unnecessary transfers, reduce documentation burden, and retain critical care patients.
Reserve spot here.
About VSee Health
VSee Health (NASDAQ:VSEE) is an AI-powered telehealth technology and services company delivering digital health solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and enterprise partners globally. VSee holds a FedRAMP High Authority to Operate (ATO) from the U.S. Department of Health and Human Services and serves clients including NASA, HHS ASPR, McKesson, DaVita, and the country of Qatar. Visit vseehealth.com.
About DocBox
DocBox (www.docboxmed.com) is dedicated to enabling data-driven healthcare. DocBox collects up to 3GB of structured data per ICU patient per day per bed and can reduce documentation time by 70 percent, giving clinicians quality time with the patient. DocBox applications allow healthcare providers to use data collected from AI, Machine Learning and Algorithms, enabling critical care to not only be at the bedside but also outside the healthcare provider's walls. The DocBox platform permits cohesive flow of data throughout the health delivery organization and provides units and hospital-wide operational metrics. It facilitates the ability to innovate utilizing rich and accurate big data sets and automatically captures billable clinical interventions.
High resolution photos available for download at https://docboxmed.com/downloads/
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company's anticipated use of proceeds from the offering; and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
Contacts:
Anne Chang
VSee Health
media@vsee.com
Michael Castorino
DocBox
info@docboxmed.com
VSee Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health
Trooperstocks
7月前
$VSEE News: VSee Health, Inc. Regains Compliance with Nasdaq Stockholders' Equity Requirement
VSee Health
Fri, December 12, 2025 at 8:00 AM EST
SAN JOSE, CALIFORNIA / ACCESS Newswire / December 12, 2025 / VSee Health, Inc. (Nasdaq:VSEE, VSEEW), a leading provider of telehealth and digital health solutions, today announced that it has regained compliance with Nasdaq Listing Rule 5550(b)(1) (the "Minimum Equity Rule").
As previously disclosed, on September 2, 2025, the Company received notice from Nasdaq that its stockholders' equity had fallen below the $2.5 million minimum required for continued listing on The Nasdaq Capital Market. Following a hearing on September 9, 2025, the Nasdaq Hearings Panel granted the Company an exception through December 1, 2025, to demonstrate compliance.
The Company is pleased to report that, through a series of strategic capital transactions completed after September 30, 2025, it has successfully increased its stockholders' equity to approximately $9.5 million on a pro forma basis as of December 1, 2025. These transactions included:
Full conversion of multiple outstanding convertible notes into common stock;
Cash exercise and exchange of certain public warrants; and
A $6.0 million private placement of common stock (or pre-funded warrants) with accompanying warrants completed on November 25, 2025.
A pro forma balance sheet reflecting these transactions as of December 1, 2025, was filed with the Securities and Exchange Commission on Form 8-K/A on December 11, 2025.
"We are very pleased to have regained compliance with Nasdaq's continued " minimum equity listing requirement," said Dr. Imo Aisiku, Co-Chief Executive Officer and of VSee Health. "These transactions have significantly strengthened our balance sheet, eliminated substantial debt and derivative liabilities, and provided the Company with additional working capital to execute our growth strategy in telehealth, remote patient monitoring, and digital health services.
About VSee Health
VSee Health (NASDAQ:VSEE) is a telehealth technology and services company delivering high-acuity virtual care solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and employers across the United States. For more information, please visit vseehealth.com.
Forward-Looking Statements
Matters discussed in this news release that are not statements of historical or current facts, including but not limited to those relating to VSee Health's ability to improve healthcare access and provider efficiencies, are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated closing of the offering; the Company's anticipated use of proceeds from the offering; and other statements that are not historical facts, including statements which may be accompanied by the words "intends," "may," "will," "plans," "expects," "anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes," "potential" or similar words. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause performance or achievements to be materially different from historical results or from any future performance or achievements expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. More information on risk factors relating to VSee Health and its technology and billing services is included from time to time in the "Cautionary Note Regarding Forward-Looking Statements," "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of VSee Health's periodic and current filings with the SEC, which are also made available on VSee Health's website at www.vseehealth.com. Forward-looking statements speak only as of the date they are made, and VSee Health undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, or otherwise. Readers are cautioned not to put undue reliance on forward-looking statements.
ProfitScout
7月前
$VSEE News: VSee and Novant Health Urgent Care Share Blueprint for Scalable, Profitable Tele-Urgent Programs
VSee Health AI telehealth technology leader highlights client success and growing market momentum in virtual care
SAN JOSE, CALIFORNIA / ACCESS Newswire / December 4, 2025 / VSee Health, Inc. (Nasdaq:VSEE), a leading provider of AI telehealth technology solutions, announces an upcoming webinar today with Novant Health Urgent Care, the largest urgent care provider in South Carolina. The event will focus on how healthcare organizations can design and scale high-return virtual urgent-care programs that combine operational efficiency with meaningful patient impact.
Hosted by Dr.?Milton?Chen, Co-CEO of VSee Health, and featuring guest speaker Natalie?Condé,?PA-C,?MMS, Director of Telemedicine of Novant Health Urgent Care, the discussion will draw on Novant?Health Urgent Care's extensive experience in telemedicine expansion and the lessons learned from building sustainable, system-wide virtual care operations.
Proven Collaboration and Measurable Impact
VSee's commitment to client-focused innovation is exemplified in its partnership with Novant?Health?Urgent?Care. Working closely with Novant?Health Urgent Care during its transition from Doctors?Care, VSee helped streamline clinic operations by enhancing and customizing digital intake forms to align with clinicians' workflows. The collaboration also included a full brand refresh-integrating new URLs, logos, and color themes seamlessly across both web and mobile platforms.
"VSee continues to expand its footprint among health systems seeking scalable, profitable virtual care," said Dr.?Milton?Chen, Co-CEO of?VSee Health. "Our mission is to help providers achieve better financial outcomes while improving patient experiences through secure, customizable digital platforms."
This engagement underscores how VSee supports urgent care providers as they expand telehealth services-driving consistent, branded patient experiences while improving administrative efficiency and financial outcomes.
Event Highlights
The live webinar will outline practical, financially focused strategies for sustaining tele-urgent programs, including:
Boosting telehealth ROI through optimized patient volumes, billing processes, and staffing models
Implementing scalable technology architectures that engage patients and enable fast service-line expansion
Leveraging AI and automation to enhance care delivery, particularly in rural or resource-constrained communities
Attendees will also gain insight into emerging trends expected to influence telehealth's growth trajectory, an industry projected to top $200?billion globally by?2030.
Registration
The webinar is free to attend. Register here.
About VSee Health
VSee Health (NASDAQ:VSEE) is an AI-powered telehealth technology and services company delivering digital health solutions through its scalable, API-driven platform. The Company's offerings integrate secure video, device data, and EHR connectivity to power hospital systems, health networks, and enterprise partners globally. VSee holds a FedRAMP High Authority to Operate (ATO) from the U.S. Department of Health and Human Services and serves clients including NASA, HHS ASPR, McKesson, DaVita, and the country of Qatar. Visit vseehealth.com
Media Contact:
Anne Chang
VSee Health
media@vsee.com
Investor Contact:
Milton Chen
VSee Health
investor@vsee.com
SOURCE: VSee Health
Hot Features
プレミアム
登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
janeyH
1週前
ErnieBilco
1月前
ihubstockmover
3月前
seventhcircle
4月前
メールアドレスで登録
